Login
Healthpeak Properties NYSE: PEAK
Healthpeak Properties (formally known as HCP) invests in real estate serving the healthcare industry and PEAK now owns 740 different properties in the medical office building, senior living and life sciences sectors
| Name | Healthpeak Properties |
| Ticker | PEAK |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
| Price | 26.60 |
| 52W Low/High | 19.95 / 37.93 |
| Market cap | 14 B |
| 1Y Total Return |
-19.91%
Average |
| 1Y Volatility |
58.07%
Average Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Healthpeak Properties (formally known as HCP) invests in real estate serving the healthcare industry and PEAK now owns 740 different properties in the medical office building, senior living and life sciences sectors
Details
| Ticker | PEAK |
| Name | Healthpeak Properties |
| ISIN | US42250P1030 |
| CUSIP | 42250P103 |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) | US S&P 500 Index |
Share as of 9/22/20
| Close Price | 26.60 |
| 52W Low/High | 19.95 / 37.93 |
| Market cap | 14 B |
| 1Y Total Return |
-19.91%
Average |
| 1Y Volatility |
58.07%
Average Risk |
| Beta | -0.07 |
| PE (trailing) |
42.22
Above Average |
| 12M Dividends | 1.48 |
| Last Dividend Date | 8/13/20 |
| Dividend Yield | 5.56% |
Fin. Strength
| Net Profit Margin | 14.5% |
| Cash from Op. / Cur. Liabilities | - |
| Diluted Earnings / Share | 0.63 |
| ROE | 5.0% |
| ROIC | 8.1% |
| Price / Revenue | 6.4 |
| Price / Book | 2.0 |
| Price / CF | 18.3 |
| Current Ratio | - |
| Cur.Liabilities / Tot.Liabilities | - |
| Financial Leverage | 0.97 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
2,243
|
1,826
|
1,846
|
2,022
|
1,782
|
2,418
|
|
| Gross Profit |
1,055
|
1,084
|
1,146
|
1,326
|
1,085
|
1,920
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
1,242
|
1,750
|
907
|
1,627
|
977
|
1,297
|
|
| Operating Income |
4
|
300
|
361
|
606
|
850
|
798
|
|
| Net Income exc. Extra |
328
|
979
|
64
|
690
|
-
|
369
|
|
| per Share | |||||||
| Diluted avg Shares |
539
|
479
|
470
|
469
|
471
|
462
|
|
| EPS exc. Extra |
0.63
|
2.06
|
0.12
|
1.45
|
-0.15
|
0.80
|
|
| Dividend |
1.48
|
1.48
|
1.48
|
1.69
|
2.28
|
2.22
|
|
| Div. Yield (an.) |
5.37%
|
4.63%
|
5.73%
|
5.27%
|
6.44%
|
5.71%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
16,316
|
13,713
|
13,451
|
14,103
|
21,116
|
22,348
|
|
| Cash, Eq & Invt ShortTerm |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Total Current Assets |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Total Non-Current Assets |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Intangibles |
538
|
318
|
294
|
414
|
551
|
577
|
|
| Total Liabilities |
8,648
|
7,094
|
8,035
|
8,074
|
11,440
|
11,821
|
|
| Total Current Liabilities |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Long Term Debt |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Shareholder equity |
7,099
|
6,054
|
5,143
|
5,702
|
9,281
|
10,233
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
785
|
790
|
855
|
979
|
1,295
|
1,235
|
|
| Depreciation |
731
|
560
|
554
|
558
|
559
|
474
|
|
| Cash from Investing |
-895
|
249
|
-239
|
1,701
|
-169
|
-2,772
|
|
| Capex |
1,252
|
54
|
717
|
914
|
528
|
1,690
|
|
| Cash from Financing |
790
|
-1,004
|
-948
|
-2,404
|
-1,112
|
1,597
|
|
| Stock Issued |
1,445
|
616
|
14
|
26
|
154
|
124
|
|
| Debt (LT) Issued |
103
|
-1,197
|
-152
|
-3,307
|
-298
|
2,530
|
|
| Free Cash Flow |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
14.5%
|
53.5%
|
3.4%
|
34.1%
|
-
|
15.2%
|
|
| NCFO / Op.Income |
20,639.6%
|
263.5%
|
237.1%
|
161.5%
|
152.3%
|
154.7%
|
|
| Current Ratio |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Financial Leverage D/E |
0.97
|
1.06
|
1.44
|
1.31
|
1.16
|
1.10
|
|
| Return on Capital Avg |
8.1%
|
24.6%
|
6.5%
|
13.0%
|
4.3%
|
7.8%
|
|
| Return on Shareholder Equity |
5.0%
|
17.4%
|
1.1%
|
9.2%
|
-
|
3.5%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available